Concord Wealth Partners Charles River Laboratories International, Inc. Transaction History
Concord Wealth Partners
- $548 Million
- Q1 2024
A detailed history of Concord Wealth Partners transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Concord Wealth Partners holds 259 shares of CRL stock, worth $52,183. This represents 0.01% of its overall portfolio holdings.
Number of Shares
259
Previous 56
362.5%
Holding current value
$52,183
Previous $13,000
438.46%
% of portfolio
0.01%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CRL
# of Institutions
728Shares Held
51.3MCall Options Held
183KPut Options Held
346K-
Vanguard Group Inc Valley Forge, PA6.05MShares$1.22 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY5.17MShares$1.04 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.09MShares$422 Million0.03% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.88MShares$378 Million1.21% of portfolio
-
Clearbridge Investments, LLC New York, NY1.51MShares$305 Million0.34% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10.2B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...